M. Celanovic

Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study

M. Fakih, Z. Linke, T. Cartwright, 2020, Cancers.

AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer

Joon Sang Lee, H. Linden, S. Chandarlapaty, 2022, Nature Communications.

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor

S. Montoto, N. Russell, E. Jantunen, 2019, Bone Marrow Transplantation.

AMEERA-1: Phase 1/2 study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with palbociclib (palbo) in postmenopausal women with ER+/ human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC).

H. Linden, P. Neven, S. Chandarlapaty, 2021 .

Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor

N. Kröger, S. Iacobelli, N. Russell, 2019, Bone Marrow Transplantation.

A Pilot, Exploratory, Randomized, Phase II Safety Study Evaluating Tumor Cell Mobilization and Apheresis Product Contamination in Patients Treated with Granulocyte Colony-Stimulating Factor Alone or Plus Plerixafor.

H. Nahi, J. Lund, V. Pečeliūnas, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

264P AMEERA-1: Subgroup analyses of phase I/II study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with palbociclib in postmenopausal women with ER+/ human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (aBC)

H. Linden, P. Neven, S. Chandarlapaty, 2021, Annals of Oncology.

Abstract 739: Preclinical and clinical activity of SAR439859, Amcenestrant, a next generation SERD

Joon Sang Lee, V. Pelekanou, L. Debussche, 2021, Endocrinology.